Last reviewed · How we verify
NCT05609916
CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD
NA trial testing Cognitive Behavioral Therapy in Cognitive Behavioral Therapy in 200 participants. Currently enrolling.
30 December 2026
Quick facts
| Lead sponsor | Baylor College of Medicine |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 30 November 2022 |
| Primary completion | 30 December 2026 |
| Estimated completion | 30 August 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cognitive Behavioral Therapy
Conditions studied
- Cognitive Behavioral Therapy — all drugs for Cognitive Behavioral Therapy →
- Obsessive-Compulsive Disorder — all drugs for Obsessive-Compulsive Disorder →
- Obsessive-Compulsive Disorder in Children — all drugs for Obsessive-Compulsive Disorder in Children →
- Obsessive-Compulsive Disorder in Adolescence — all drugs for Obsessive-Compulsive Disorder in Adolescence →
Sponsor
Baylor College of Medicine
Who can join
Adults 7 to 17, any sex, with Cognitive Behavioral Therapy or Obsessive-Compulsive Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine whether youth with OCD who benefit from CBT augmentation to SRI can discontinue their medication without relapse over 24 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05609916
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive Behavioral Therapy
Trials testing the same drug.
- NCT06786429 — Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. · Phase 4 · not yet recruiting
- NCT07503951 — Cognitive Behavior Therapy in Psychiatric Inpatient Care · NA · not yet recruiting
- NCT05943171 — A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT · NA · recruiting
- NCT07399431 — Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia · NA · completed
- NCT07432139 — Brief Emotion-Focused Therapy for Self-Criticism: A Comparison With a Cognitive-Behavioral Therapy Approach · NA · completed
Other recruiting trials for Cognitive Behavioral Therapy
Currently open trials in the same condition.
- NCT07232823 — Brief Culturally Adapted CBT for OCD · NA · recruiting
- NCT06454695 — Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery · NA · recruiting
- NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
- NCT04761328 — Fear of Recurrence and Stopping Immunotherapy · NA · recruiting
- NCT04700878 — A Randomized Controlled Evaluation of a Compassion-course for Healthcare Professionals · NA · recruiting
Other Baylor College of Medicine trials
Trials by the same sponsor.
- NCT07513194 — GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) · Phase 1 · not yet recruiting
- NCT05855824 — Toddler Biomarker of Nutrition Study · NA · not yet recruiting
- NCT06738628 — Disposable Endoscope Platform in Third Space Endoscopic Procedures · not yet recruiting
- NCT06834997 — Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital · Phase 2 · withdrawn
- NCT07387614 — WEB-BASED SUPPORT PROGRAM FOR CAREGIVERS OF VETERANS WITH DEMENTIA DISCHARGED FROM SKILLED NURSING FACILITIES TO HOME · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05609916 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Baylor College of Medicine
- Last refreshed: 20 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05609916.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing